*This is the Global version of our site. For specific country information, please choose from the dropdown.
Committed to creating vaccines
to help protect health
to help protect health
Novavax is a global biotechnology company with a proven vaccine technology. We’re focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. With a strong scientific foundation, our technology includes both our recombinant protein-based nanoparticle and Matrix-M™ adjuvant.
Our approach to science
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to help prevent serious infectious diseases.
Our vaccine and adjuvant technology can be applied to address current and emerging global health threats including respiratory diseases and other infectious diseases.
Our leadership
Our team has unparalleled experience developing vaccines, conducting early proof-of-concept and clinical development work, and executing successful partnerships for further development and commercialization. Their immense depth of experience is ideally suited to exponentially increase the public health impact of our recombinant protein-based nanoparticle and Matrix-M™ adjuvant technology, while driving value for the Company.
